← Back to Discover
Saturn V Capital Management LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $697,467,372
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- AMYLYX PHARMACEUTICALS INC · COM · 03237H101 · shares: $83,048,854
- ALUMIS INC · COM · 022307102 · shares: $82,040,566
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $69,143,950
- VAXCYTE INC · COM · 92243G108 · shares: $49,579,891
- IMMIX BIOPHARMA INC · COM · 45258H106 · shares: $48,028,403
- PHARVARIS N V · COM · N69605108 · shares: $45,442,339
- JAZZ PHARMACEUTICALS PLC · SHS USD · G50871105 · shares: $38,781,230
- CELCUITY INC · COM · 15102K100 · shares: $38,742,669
- DISC MEDICINE INC · COM · 254604101 · shares: $38,378,752
- CANDEL THERAPEUTICS INC · COM · 137404109 · shares: $34,027,966
Reported holdings
23 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | — | 4,624,101 shares | $83,048,854 |
| ALUMIS INC | COM | 022307102 | — | 2,915,443 shares | $82,040,566 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 518,865 shares | $69,143,950 |
| VAXCYTE INC | COM | 92243G108 | — | 852,914 shares | $49,579,891 |
| IMMIX BIOPHARMA INC | COM | 45258H106 | — | 4,658,429 shares | $48,028,403 |
| PHARVARIS N V | COM | N69605108 | — | 1,314,122 shares | $45,442,339 |
| JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | — | 160,938 shares | $38,781,230 |
| CELCUITY INC | COM | 15102K100 | — | 370,318 shares | $38,742,669 |
| DISC MEDICINE INC | COM | 254604101 | — | 524,730 shares | $38,378,752 |
| CANDEL THERAPEUTICS INC | COM | 137404109 | — | 3,303,686 shares | $34,027,966 |
| X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | — | 6,973,343 shares | $32,565,512 |
| MONOPAR THERAPEUTICS INC | COM NEW | 61023L207 | — | 311,976 shares | $28,885,858 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 1,057,493 shares | $23,486,920 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 1,052,043 shares | $19,620,602 |
| ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | — | 2,101,119 shares | $12,396,602 |
| SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | — | 1,479,918 shares | $11,439,766 |
| OCULIS HOLDING AG | ORDINARY SHARES | H5870P102 | — | 684,880 shares | $9,499,286 |
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | — | 3,869,056 shares | $7,854,184 |
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | — | 770,643 shares | $7,852,852 |
| INVIVYD INC | COM | 00534A102 | — | 8,392,288 shares | $7,321,432 |
| ALTO NEUROSCIENCE INC | COM SHS | 02157Q109 | — | 182,829 shares | $4,824,857 |
| SATELLOS BIOSCIENCE INC | COM | 80401L803 | — | 350,000 shares | $2,721,250 |
| OVID THERAPEUTICS INC | COM | 690469101 | — | 663,060 shares | $1,783,631 |